Abstract:Shan Li, 1, &ast Fengdi Zhang, 2, &ast Ritian Lin, 1 Qinjuan Sun, 1 Lihong Qu, 2 Lan Zhong 1 1 Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; 2 Department of Infectious Diseases, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lan Zhong, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, 150, Jimo Road, Pudong New Area, Shanghai, 200120, People's Republic of China, Email Lihong Qu, Department of Infectious Diseases, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China, Email Purpose: The rapid global spread of the SARS-CoV-2 Omicron variant introduces a novel complication: the emergence of IBD (inflammatory bowel disease)-like ulcers in certain patients. This research delves into this new challenge by juxtaposing the clinical manifestations and genetic expression patterns of individuals affected by the Omicron variant of COVID-19 with those diagnosed with IBD. It aims to decode the link between these conditions, potentially shedding light on previously unexplored facets of COVID-19 pathophysiology. This investigation emphasizes gene expression analysis as a key tool to identify wider disease correlations and innovative therapeutic avenues. Patients and Methods: From March to December 2022, patients with SARS-CoV-2 Omicron infection and inflammatory bowel disease and healthy controls were recruited in Shanghai East Hospital, Shanghai, China. The epidemiological and clinical characteristics of the patients were compared. Four RNA sequencing datasets (GSE205244, GSE201530, GSE174159, and GSE186507) were extracted from the Gene Expression Omnibus database to detect mutually differentially expressed genes and common pathways in patients with SARS-CoV-2 infection and inflammatory bowel disease. Results: Compared to patients with active inflammatory bowel disease, patients with SARS-CoV-2 infection were more likely to have elevated interferon-α levels and an increased lymphocyte count and less likely to have high interleukin-6, tumor necrosis factor-α, and C-reactive protein levels and an elevated neutrophil count. A total of 51 common differentially expressed genes were identified in the four RNA-sequencing datasets. Enrichment analysis suggested that these genes were related to inflammation and the immune response, especially the innate immune response and nucleotide oligomerization domain-like receptor signaling pathway. Conclusion: The inflammation and immune-response pathways in COVID-19 and inflammatory bowel disease have several similarities and some differences. The study identifies the NLR signaling pathway's key role in both COVID-19 and IBD, suggesting its potential as a target for therapeutic intervention and vaccine development. Keywords: viral-induced inflammation, omicron infection, RNA sequencing, gene expression in infection, inflammatory bowel disease Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread worldwide rapidly over the past 4 years. 1 After infection with SARS-CoV-2, some patients have been reported to develop long-term symptoms or health problems, a phenomenon known as Long-COVID. 2 Long COVID, impacting at least 10% of individuals infected by SARS-CoV-2, presents a compelling case for further investigation due to its extensive symptomatology affecting multiple organ systems. Gastrointestinal symptoms of Long COVID are associated with persistent SARS-CoV-2 replication in the intestinal mucosa, including nausea, abdominal pain, loss of appetite, and constipation, with significant changes in the composition of the gut microbiota. 3,4 Interestingly, during the COVID-19 epidemic in Shanghai, some patients who underwent colonoscopy for gastrointestinal symptoms following COVID-19 were found to have inflammatory bowel disease (IBD)-like ulcers. Similar cases have also been reported by other researchers. 5 IBD is a group of heterogenous, chronic, non-specific intestinal inflammatory diseases with elusive etiology and pathogenesis, clinically classified as Crohn's disease (CD) and ulcerative colitis (UC). UC is confined to the colon and can lead to ulceration, severe bleeding, toxic megacolon, and fulminant colitis. 6 CD can involve any part of the digestive tract and is characterized by transmural inflammation that can lead to complicati -Abstract Truncated-

Technical Note - The Asymptotic Extreme Value Distribution of the Sample Minimum of a Concave Function under Linear Constraints

"Open and Shut" for Guests in Molybdenum-Oxide-Based Giant Spheres, Baskets, and Rings Containing the Pentagon as a Common Structural Element.

Combinatorial Statistics on Alternating Permutations

P448 The role of SARS-CoV2 infection in the clinical outcomes of patients with Inflammatory Bowel Disease

The effect of azathioprine, hydrocortisone and trimethazone on the occurrence of active lymphocytes in liver of endotoxin treated rabbits.

Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations

I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections

COVID-19 and immunomodulation in IBD

Practice Patterns of Medical Management of Inflammatory Bowel Disease During Pandemic of COVID-19: A Global Survey of Health Care Providers

What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon

Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?

Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China

Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19

Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges

[LIPOID DERMATO-ARTHRITIS, RETICULO-HISTIOCYTOSIS OF THE SKIN AND JOINTS].

Shared Immune Associations Between COVID-19 and Inflammatory Bowel Disease: A Cross-Sectional Observational Study in Shanghai, China

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges

In situ observation of nanograin rotation and deformation in nacre.

Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response